More broadly, the fuss over testosterone seems to have run its course, the outcome being that there was no reason for concern. It's possible that there will be a rebound in sales as a consequence (anyone know when the figurres are duee out?), and perhaps also a decline in the misleading and indeed fraudulent attempts by law firms to drum up business in the form of law suits. Here's hoping.
Acrux Limited Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 . Venue: Westin, page-3
Add to My Watchlist
What is My Watchlist?
